"M" Extract

Dilute 10 cc into 6 oz. of water, drink solution 2-4 times daily.

Methylglyoxal is a natural compound that exists in our normal cell. Dr. Albert Szent-Gyorgyi, Nobel Prize winner in Medicine, spent over 40 years of his life studying and researching the abnormal cancer physiology and developed several cancer treatment. He has stated that a normal cell is very much like a car, when the cell reproduces, they accelerate, when they finished reproducing, the brakes come on and stop the cell growth. Dr. Szent-Gyorgyi described that cancer cell is very much like a car which still has the accelerator working, but the brakes no longer worked. Once accelerated in reproducing cells, it is unable to stop the growth, therefore, it continues to grow abnormally and uncontrollably, very much like a run away car going downhill.

In many of his research articles and books, Dr. Szent-Gyorgyi described Glyoxal and Methylglyoxal as the missing compound in cancer cells which allows for normal “brake” into cell reproduction. He described a simple and yet effective approach of replacing methylglyoxal to those cells in order to help the normal physiology of the cells to stop growing uncontrollably. His theory was proven correct in vitro and in vivo by many independent research as well as the clinical trials using methylglyoxal available with the following article published in the Journal. The solution is 0.4 molar concentration of Methylglyoxal, and the abstract called for 10 cc of this solution diluted in 6 oz. of water to be taken 4 times a day with individual participants follows by oral doses of vitamin B12 and B complex as well as chewable vitamin C right after taking each dose.

Title: Implication of the bioelectronics principle in cancer therapy : Treatment of cancer patients by methylglyoxal-based formulation.

Authors : Manju Ray1*, Swapna Ghosh1, Manoj Kar2, Santajit Datta† and Subhankar Ray3
1Department of Biological Chemistry 2Department of Biophysics Molecular Biology and Genetics
University College of Science3Department of Biochemistry, University College of Science †Medical Practitioner

Abstract: Based on our previous in vitro studies with human cells and in vivo studies with animals we had developed an anticancer formulation with methylglyoxal as the lead ingredient. This formulation has a tumoricidal effect by inhibiting specifically in cancerous cells the electron flow and the transfer of reducing equivalent necessary for the production of adenosine-5’ -triphosphate, the cellular energy currency. By keeping this remarkable property in mind, we had treated 24 patients suffering from different types of malignancy (mostly in very advanced stage of the disease) with this methylglyoxal-based formulation. The results indicate a dramatic positive effect on the patients. Out of the 24 patients, 11 are in excellent physical condition, the condition of 5 patients can be considered stable. The rest had either opted out from the treatment or died during the course of the study. These results strongly suggest that this formulation is by far more superior to other present forms of treatment against cancer. It is imperative that this formulation be widely used in treating cancer patients, as well as to attempt the improvement of its efficacy.

Top of page